To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Most Popular in Claims/Labeling
- 1Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics
- 2FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 3The INCI Name Game: A Commentary
- 4The EU Fragrance Allergens
- 5Make Your Claims Bulletproof: Let Science Serve as Your Vest
- 6Big Win for Cosmetics: Court Closes Prop 65 Titanium Dioxide Case
- 7Words from Wiechers: High-resolution Resolutions
- 8Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure
- 9VIDEO: Seki's Schroeder on toxicological profiling, animal testing ban
- 10Beginner's Guide to Natural/Organic
- Beginner's Guide to Natural/Organic
2/5/2019, John I. Yablonski, Bio-Control Consultants, LLC, Park City, UT, and David R. Winne, Claims Support Group, LLC, Cold Spring, NY
- Back to Basics, Part II: Ensuring Product Safety
4/29/2019, Pascal Yvon, BioSciences Expansion, LLC, Newtown, PA U.S.
- The INCI Name Game: A Commentary
7/12/2019, Rachel Grabenhofer
- Claire's, Beauty Plus Global Recall Certain Cosmetics After Asbestos Testing
6/7/2019, Brooke Schleehauf
- Back to Basics: Making Room for Regulatory Compliance
1/3/2019, Pascal Yvon, BioSciences Expansion, LLC, Newtown, PA USA